CURRICULUM VITAE Doç. Dr. Uğur SELEK Amerikan Hastanesi

CURRICULUM VITAE Doç. Dr. Uğur SELEK Amerikan Hastanesi

Doç Dr Uğur SELEK
1
CURRICULUM VITAE
Doç. Dr. Uğur SELEK
Amerikan Hastanesi-M.D. Anderson Radyasyon Onkolojisi Merkezi Bölüm Başkanı
Teksas Üniversitesi, M. D. Anderson Radyasyon Onkolojisi Öğretim Üyesi
EĞITIM
1979-1984
1984-1991
1991-1997
1997-2001
2001-2002
2002-2003
2003-2004
2004-2005
2005-2006
2006-2008
2009-
Afyon Atatürk İlkokulu
Usak Anadolu Lisesi
Hacettepe Üniversitesi İngilizce Tıp Fakültesi (HÜTF)
HÜTF Radyasyon Onkolojisi Anabilim Dalı İhtisası
Klinik Fellow
Yoğunluk Ayarlı ve 3-Boyutlu Konformal Radyoterapi Programı,
Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon
Onkolojisi Bölümü, Houston, Teksas, ABD
Klinik Fellow
Yoğunluk Ayarlı ve Stereotaktik Radyoterapi Programı,
Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon
Onkolojisi Bölümü, Houston, Teksas, ABD
Uzman Doktor, HÜTF Radyasyon Onkolojisi Anabilim Dalı
Yard. Doç. Dr., HÜTF Radyasyon Onkolojisi Anabilim Dalı
Yedek Subay, GATA Radyasyon Onkolojisi Anabilim Dalı
Doç. Dr., HÜTF Radyasyon Onkolojisi Anabilim Dalı
Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi
AKADEMİK HAYAT
1997
1998
2001
2001-3
2006
2009
Tıp Doktoru, HÜTF
Educational Commission for Foreign Medical Graduates Certification
Radyasyon Onkolojisi Uzmanı, HÜTF
Klinik Fellow, Teksas Üniversitesi, MD Anderson Kanser Merkezi,
Radyasyon Onkolojisi Bölümü, Houston, Teksas, ABD
Doçent Doktor, HÜTF
Doç. Dr., Teksas Üniversitesi M. D. Anderson Radyasyon Onkolojisi
Doç Dr Uğur SELEK
ÖDÜL
2003
“First Annual M. D. Anderson Radiation Oncology Fellow Research
Award”, Teksas Üniversitesi, MD Anderson Kanser Merkezi, Radyasyon
Onkolojisi Bölümü, Houston, Teksas, ABD
ÜYELIKLER
12345-
ASTRO
EORTC
Türk Radyasyon Onkolojisi Derneği
Türk Akciğer Kanseri Derneği
M. D. Anderson Cancer Center Alumni and Faculty Association
ULUSLARARASI KONGRE GÖREV VE HAKEMLİKLERİ
1. 2009 American Society of Radiation Oncology (ASTRO), 51. Yıllık Kongresi,
Şikago, ABD, Kasım 1-5: Poster Tartışması Moderatörü
2. 2009 American Society of Radiation Oncology (ASTRO), 51. Yıllık Kongresi,
Şikago, ABD, Kasım 1-5: Bildiri Hakemi
3. 2008 American Society of Radiation Oncology (ASTRO), 50. Yıllık Kongresi,
Boston, ABD, Eylül 21-25: Bildiri Hakemi
ULUSLARARASI DERGİ HAKEMLİKLERİ
1. International Journal of Radiation Oncology Biology Physics (ISSN: 0360-3016)
2. Head And Neck-Journal For The Sciences And Specialties Of The Head And
Neck (ISSN: 1043-3074)
3. Journal of Experimental & Clinical Cancer Research (ISSN: 1756-9966)
4. Tohoku Journal Of Experimental Medicine (ISSN: 0040-8727)
5. Journal of Palliative Medicine (ISSN: 1096-6218)
6. Journal of the National Medical Association (ISSN: 0027-9684)
7. Uluslararası Hematoloji-Onkoloji Dergisi (ISSN: 1306-133X)
8. Turkiye Klinikleri Tıp Bilimleri Dergisi (ISSN: 1300-0292)
YAYINLAR
Uluslararası Kitap Bölümleri
1. Selek U, Chang EL. Skull base and posterior fossa. In: Chao KSC, Ozyigit O,
Apisarnthanarax S, editors. Practical essentials of Intensity Modulated Radiation
Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. pp. 82-104
2. Ozyigit G, Selek U. Oral cavity. In: Chao KSC, Ozyigit O, Apisarnthanarax S,
editors. Practical essentials of Intensity Modulated Radiation Therapy.
Philadelphia, PA: Lippincott Williams & Wilkins; 2005. pp. 153-165.
Science Citation Index Expanded Yayınları
2
Doç Dr Uğur SELEK
3
1-
Zorlu F, Selek U, Kiratli H. Initial Results Of Fractionated Cyberknife®
Radiosurgery For Uveal Melanoma. J Neurooncol. 2009 Feb 22. [Epub
ahead of print]
2-
Topkan E, Yildirim BA, Selek U, Yavuz MN. Cranial Prophylactic
Irradiation in Locally Advanced Non-Small Cell Lung Carcinoma: Current
Status and Future Perspectives. Oncology. 2009;76(3):220-8. Epub 2009
Feb 13.
3-
Zorlu AF, Selek U, Emri S, Gurkaynak M, Akyol FH. Second line
palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung
carcinoma. Yonsei Med J. 2008 Aug 30;49(4):620-4.
4-
Harputluoglu H, Dizdar O, Aksoy S, Kilickap S, Dede DS, Ozisik Y, Guler
N, Barista I, Gullu I, Hayran M, Selek U, Cengiz M, Zorlu F, Tekuzman G,
Altundag K. Characteristics of breast cancer patients with central nervous
system metastases: a single-center experience. J Natl Med Assoc. 2008
May;100(5):521-6.
5-
Atahan IL, Ozyigit G, Yildiz F, Gurkaynak M, Selek U, Sari S, Hayran M.
Percent positive axillary involvement predicts for the development of brain
metastasis in high-risk patients with nonmetastatic breast cancer receiving
post-mastectomy radiotherapy. Breast J. 2008 May-Jun;14(3):245-9. Epub
2008 Apr 21.
6-
Gultekin M, Selek U, Ozyigit G, Cengiz M, Yavas O, Yildiz F. Boost dose
back again in elderly. J Clin Oncol. 2007 Dec 20;25(36):5843-4; author
reply 5844-5.
7-
Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran
M. Percent positive axillary lymph node metastasis predicts survival in
patients with non-metastatic breast cancer. Acta Oncol. 2008;47(2):232-8.
8-
Cengiz M, Yildiz F, Selek U, Ozyigit G. Comment on "computed
tomography versus magnetic resonance imaging-based contouring in
cervical cancer brachtherapy: results of a prospective trial and preliminary
guidelines for standardized contours" by Viswanathan et Al. (Int j radiat
oncol biol phys 2007;68:491-498, 2007). Int J Radiat Oncol Biol Phys. 2007
Nov 1;69(3):963; author reply 963-4.
9-
Yazici G, Selek U, Yildiz F, Ozyigit G, Cengiz M. Is mastectomy superior
to breast-conserving treatment for young women? In regard to Coulombe et
Al. (Int j radiat oncol biol phys 2007;67:1282-1290). Int J Radiat Oncol Biol
Phys. 2007 Oct 1;69(2):640; author reply 640.
Doç Dr Uğur SELEK
4
10-
Cengiz M, Gürdalli S, Selek U, Yildiz F, Saglam Y, Ozyar E, Atahan IL.
Effect of bladder distension on dose distribution of intracavitary
brachytherapy for cervical cancer: three-dimensional computed tomography
plan evaluation. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):464-8.
Epub 2007 Sep 4.
11-
Ozyigit G, Selek U, Cengiz M, Yildiz F. Comment on "Cranial location of
level II lymph nodes in laryngeal cancer: implications for elective nodal
target volume delineation": in regard to Braam et al. (Int J Radiat Oncol Biol
Phys 2007;67:462-468). Int J Radiat Oncol Biol Phys. 2007 Aug
1;68(5):1582-3; author reply 1583.
12-
Selek U, Zorlu F, Hurmuz P, Cengiz M, Turker A, Soylemezoglu F,
Gurkaynak M. Craniospinal radiotherapy in adult medulloblastoma.
Strahlenther Onkol. 2007 May;183(5):236-40.
13-
Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F. Long-term outcome
and prognostic factors in patients with cervical carcinoma: a retrospective
study. Int J Gynecol Cancer. 2007 Jul-Aug;17(4):833-42. Epub 2007 Mar
15.
14-
Varan A, Akyüz C, Akalan N, Atahan L, Söylemezoglu F, Selek U, Yalçin
B, Kutluk T, Büyükpamukçu M. Astrocytic tumors in children: treatment
results from a single institution. Childs Nerv Syst. 2007 Mar;23(3):315-9.
Epub 2006 Oct 13.
15-
Cengiz M, Cetin E, Yildiz F, Selek U, Aydinkarahaliloglu E. Change in
blood chemistry may explain higher toxicity of total body irradiation for
bone marrow transplantation. Med Hypotheses. 2007;68(3):554-7. Epub
2006 Oct 2.
16-
Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M,
Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin
M, Abacioğlu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan
IL. Treatment results of 165 pediatric patients with non-metastatic
nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol.
2006 Oct;81(1):39-46. Epub 2006 Sep 11.
17-
Yildiz F, Genc M, Akyurek S, Cengiz M, Ozyar E, Selek U, Atahan IL.
Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy
versus 6 Gy. J Natl Med Assoc. 2006 Jul;98(7):1136-9.
18-
Akyol F, Selek U, Ozyigit G, Onal C, Akdogan B, Karabulut E, Ozen H.
Preliminary results of bicalutamide monotherapy on biochemical failure of
localized prostate cancer. J Natl Med Assoc. 2006 Jul;98(7):1058-61.
Doç Dr Uğur SELEK
5
19-
Yazici G, Yildiz F, Cengiz M, Ozyigit G, Selek U, Genç M, Atahan IL. Use
of CT simulation for treatment of cervical cancer to assess the adequacy of
lymph node coverage of conventional pelvic fields based on bony
landmarks: In regard to Finlay et al. (Int J Radiat Oncol Biol Phys
2006;64:205-209). Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1594;
author reply 1594.
20-
Cağlar K, Varan A, Akyüz C, Selek U, Kutluk T, Yalçin B, Atahan IL,
Büyükpamukçu M. Second neoplasms in pediatric patients treated for
cancer: a center's 30-year experience. J Pediatr Hematol Oncol. 2006
Jun;28(6):374-8.
21-
Atahan L, Yildiz F, Selek U, Sari S, Gurkaynak M. Postoperative
radiotherapy in the treatment of male breast carcinoma: a single institute
experience. J Natl Med Assoc. 2006 Apr;98(4):559-63.
22-
Zorlu F, Selek U, Onal C, Söylemezoğlu F, Gurkaynak M. Postoperative
radiotherapy in cranial ganglioglioma. J Neurooncol. 2006 May;77(3):3214.
23-
Zorlu F, Selek U, Soylemezoglu F, Oge K. Malignant giant cell tumor of
the skull base originating from clivus and sphenoid bone. J Neurooncol.
2006 Jan;76(2):149-52.
24-
Zorlu F, Selek U, Akyuz C, Ozturk A, Soylemezoglu F, Akalan N. Spinal
seeding of a pilocytic astrocytoma following multiple subtotal resections.
Pediatr Neurosurg. 2005 Sep-Oct;41(5):248-52.
25-
Zorlu F, Selek U, Ulger S, Donmez T, Erden E. Paraganglioma in sella. J
Neurooncol. 2005 Jul;73(3):265-7.
26-
Akyol F, Ozyigit G, Selek U, Karabulut E. PSA bouncing after short term
androgen deprivation and 3D-conformal radiotherapy for localized prostate
adenocarcinoma and the relationship with the kinetics of testosterone. Eur
Urol. 2005 Jul;48(1):40-5.
27-
Selek U, Cengiz M, Ozyigit G, Yildiz F, Lale Atahan I. Comment on: "HIV
infection and invasive cervical cancers, treatment with radiation therapy:
toxicity and outcome" [Radiother Oncol 2005;74:31-35, Shrivastava et al.].
Radiother Oncol. 2005 Jul;76(1):107-8; author reply 108.
28-
Cengiz M, Selek U, Genç M, Aydinkarahaliloglu E, Yildiz F. Comment on
"Correlation between the treated volume, the GTV and the CTV at the time
of brachytherapy and histopathologic findings in 33 patients with operable
cervix carcinoma". Radiother Oncol. 2005 Jun;75(3):367-8; author reply
368-9.
Doç Dr Uğur SELEK
6
29-
Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A,
Sawaya R, Woo SY. Outcome variation among "radioresistant" brain
metastases treated with stereotactic radiosurgery. Neurosurgery. 2005
May;56(5):936-45; discussion 936-45.
30-
Ozyigit G, Selek U, Cengiz M, Yildiz F. Comment on: "Target dose
conformity in 3-dimensional conformal radiotherapy and intensity
modulated radiotherapy" Wu et al. [Radiother Oncol 2004; 71:201-206].
Radiother Oncol. 2005 Jan;74(1):78; author reply 78-9.
31-
Cengiz M, Selek U, Yildiz F, Sari S. Comment on: "Escalated
hyperfractionated accelerated radiation therapy for locally advanced nonsmall cell lung cancer: a clinical Phase II trial" Radiother Oncol 71(2):157162, 2004 by Dr Chen et al.]. Radiother Oncol. 2005 Jan;74(1):76-7; author
reply 77-8.
32-
Selek U, Ozyar E, Ozyigit G, Varan A, Buyukpamukcu M, Atahan IL.
Treatment results of 59 young patients with nasopharyngeal carcinoma. Int J
Pediatr Otorhinolaryngol. 2005 Feb;69(2):201-7.
33-
Yildiz F, Kars A, Cengiz M, Yildiz O, Akyürek S, Selek U, Ozyigit G,
Atahan IL. 1,25-Dihydroxy vitamin D3: can it be an effective therapeutic
option for aggressive fibromatosis. Med Hypotheses. 2005;64(2):333-6.
34-
Rosenthal DI, Barker JL Jr, El-Naggar AK, Glisson BS, Kies MS, Diaz EM
Jr, Clayman GL, Demonte F, Selek U, Morrison WH, Ang KK, Chao KS,
Garden AS. Sinonasal malignancies with neuroendocrine differentiation:
patterns of failure according to histologic phenotype. Cancer. 2004 Dec
1;101(11):2567-73.
35-
Selek U, Chang EL, Hassenbusch SJ 3rd, Shiu AS, Lang FF, Allen P,
Weinberg J, Sawaya R, Maor MH. Stereotactic radiosurgical treatment in
103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol
Phys. 2004 Jul 15;59(4):1097-106.
36-
Selek U, Cheung R, Lii M, Allen P, Steadham RE, Vantreese TR Jr, Little
DJ, Rosen II, Kuban D. Erectile dysfunction and radiation dose to penile
base structures: a lack of correlation. Int J Radiat Oncol Biol Phys. 2004 Jul
15;59(4):1039-46.
37-
Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK.
Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat
Oncol Biol Phys. 2004 Jul 1;59(3):743-51.
Doç Dr Uğur SELEK
7
38-
Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F. Radiotherapy
after surgery for benign cerebral meningioma. Radiother Oncol. 2004
Apr;71(1):85-90.
39-
Soyuer S, Chang EL, Selek U, McCutcheon IE, Maor MH. Intracranial
meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases
and review of the literature. Cancer. 2004 Apr 1;100(7):1491-7. Review.
40-
Selek U, Lee A, Levy L, Kuban DA. Utility of the percentage of positive
prostate biopsies in predicting PSA outcome after radiotherapy for patients
with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2003
Nov 15;57(4):963-7.